• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

将 F-FDG PET/CT 影像组学与身体成分相结合,以增强食管癌患者的预后评估。

Integrating F-FDG PET/CT radiomics and body composition for enhanced prognostic assessment in patients with esophageal cancer.

机构信息

Department of Nuclear Medicine, The First Affiliated Hospital of Soochow University, Suzhou, 215006, China.

Department of Nuclear Medicine, Shuyang Hospital Affiliated to Medical College of Yangzhou University, Suqian, China.

出版信息

BMC Cancer. 2024 Nov 14;24(1):1402. doi: 10.1186/s12885-024-13157-x.

DOI:10.1186/s12885-024-13157-x
PMID:39543534
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11566154/
Abstract

BACKGROUND

This study aimed to develop a predictive model utilizing radiomics and body composition features derived from F-FDG PET/CT scans to forecast progression-free survival (PFS) and overall survival (OS) outcomes in patients with esophageal squamous cell carcinoma (ESCC).

METHODS

We analyzed data from 91 patients who underwent baseline F-FDG PET/CT imaging. Radiomic features extracted from PET and CT images and subsequent radiomics scores (Rad-scores) were calculated. Body composition metrics were also quantified, including muscle and fat distribution at the L3 level from CT scans. Multiparametric survival models were constructed using Cox regression analysis, and their performance was assessed using the area under the time-dependent receiver operating characteristic (ROC) curve (AUC) and concordance index (C-index).

RESULTS

Multivariate analysis identified Rad-score (P = 0.003), sarcopenia (P < 0.001), and visceral adipose tissue index (VATI) (P < 0.001) as independent predictors of PFS. For OS, Rad-score (P = 0.001), sarcopenia (P = 0.002), VATI (P = 0.037), stage (P = 0.042), and body mass index (BMI) (P = 0.008) were confirmed as independent prognostic factors. Integration of the Rad-score with clinical variables and body composition parameters enhanced predictive accuracy, yielding C-indices of 0.810 (95% CI: 0.737-0.884) for PFS and 0.806 (95% CI: 0.720-0.891) for OS.

CONCLUSIONS

This study underscored the potential of combining Rad-score with clinical and body composition data to refine prognostic assessment in ESCC patients.

摘要

背景

本研究旨在开发一种预测模型,利用来自 F-FDG PET/CT 扫描的影像组学和身体成分特征来预测食管鳞状细胞癌(ESCC)患者的无进展生存期(PFS)和总生存期(OS)结局。

方法

我们分析了 91 例基线 F-FDG PET/CT 成像患者的数据。从 PET 和 CT 图像中提取影像组学特征并计算相应的影像组学评分(Rad-score)。还定量了身体成分指标,包括 CT 扫描 L3 水平的肌肉和脂肪分布。使用 Cox 回归分析构建多参数生存模型,并使用时间依赖性接收器操作特征(ROC)曲线下面积(AUC)和一致性指数(C-index)评估其性能。

结果

多变量分析确定 Rad-score(P=0.003)、肌肉减少症(P<0.001)和内脏脂肪组织指数(VATI)(P<0.001)是 PFS 的独立预测因子。对于 OS,Rad-score(P=0.001)、肌肉减少症(P=0.002)、VATI(P=0.037)、分期(P=0.042)和体重指数(BMI)(P=0.008)被确认为独立的预后因素。Rad-score 与临床变量和身体成分参数的整合提高了预测准确性,PFS 的 C-index 为 0.810(95%CI:0.737-0.884),OS 的 C-index 为 0.806(95%CI:0.720-0.891)。

结论

本研究强调了将 Rad-score 与临床和身体成分数据相结合以细化 ESCC 患者预后评估的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b1f/11566154/cf98c52b4be0/12885_2024_13157_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b1f/11566154/42a698895379/12885_2024_13157_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b1f/11566154/d82908c5e5c9/12885_2024_13157_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b1f/11566154/29e6f386e5bc/12885_2024_13157_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b1f/11566154/d1ab3ab21bb5/12885_2024_13157_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b1f/11566154/cf98c52b4be0/12885_2024_13157_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b1f/11566154/42a698895379/12885_2024_13157_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b1f/11566154/d82908c5e5c9/12885_2024_13157_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b1f/11566154/29e6f386e5bc/12885_2024_13157_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b1f/11566154/d1ab3ab21bb5/12885_2024_13157_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b1f/11566154/cf98c52b4be0/12885_2024_13157_Fig5_HTML.jpg

相似文献

1
Integrating F-FDG PET/CT radiomics and body composition for enhanced prognostic assessment in patients with esophageal cancer.将 F-FDG PET/CT 影像组学与身体成分相结合,以增强食管癌患者的预后评估。
BMC Cancer. 2024 Nov 14;24(1):1402. doi: 10.1186/s12885-024-13157-x.
2
Prognostic value of F-FDG PET radiomics and sarcopenia in patients with oral squamous cell carcinoma.18F-FDG PET 影像组学与骨骼肌减少症对口腔鳞状细胞癌患者预后的预测价值。
Med Phys. 2024 Jul;51(7):4907-4921. doi: 10.1002/mp.16949. Epub 2024 Jan 22.
3
A F-FDG PET/CT-based deep learning-radiomics-clinical model for prediction of cervical lymph node metastasis in esophageal squamous cell carcinoma.基于 F-FDG PET/CT 的深度学习-放射组学-临床模型预测食管鳞癌颈淋巴结转移。
Cancer Imaging. 2024 Nov 12;24(1):153. doi: 10.1186/s40644-024-00799-0.
4
A prognostic nomogram for T3N0M0 esophageal squamous cell carcinoma patients undergoing radical surgery based on computed tomography radiomics and inflammatory nutritional biomarkers.基于 CT 影像组学和炎症营养生物标志物的 T3N0M0 食管鳞癌根治术后患者的预后列线图
J Appl Clin Med Phys. 2024 Nov;25(11):e14504. doi: 10.1002/acm2.14504. Epub 2024 Sep 6.
5
Development and validation of an [F]FDG-PET/CT radiomic model for predicting progression-free survival for patients with stage II - III thoracic esophageal squamous cell carcinoma who are treated with definitive chemoradiotherapy.用于预测接受根治性放化疗的II - III期胸段食管鳞状细胞癌患者无进展生存期的[F]FDG-PET/CT放射组学模型的开发与验证
Acta Oncol. 2023 Feb;62(2):159-165. doi: 10.1080/0284186X.2023.2178859. Epub 2023 Feb 15.
6
A nomogram based on pretreatment radiomics and dosiomics features for predicting overall survival associated with esophageal squamous cell cancer.一种基于治疗前影像组学和剂量组学特征的列线图,用于预测食管鳞状细胞癌的总生存期。
Eur J Surg Oncol. 2024 Jul;50(7):108450. doi: 10.1016/j.ejso.2024.108450. Epub 2024 Jun 4.
7
The role of spleen radiomics model for predicting prognosis in esophageal squamous cell carcinoma patients receiving definitive radiotherapy.脾脏影像组学模型在预测接受根治性放疗的食管鳞状细胞癌患者预后中的作用。
Thorac Cancer. 2024 Apr;15(12):947-964. doi: 10.1111/1759-7714.15276. Epub 2024 Mar 13.
8
Diffusion-weighted MRI and F-FDG PET/CT in assessing the response to neoadjuvant chemoradiotherapy in locally advanced esophageal squamous cell carcinoma.弥散加权 MRI 联合 F-FDG PET/CT 评估局部进展期食管鳞癌新辅助放化疗疗效
Radiat Oncol. 2021 Jul 19;16(1):132. doi: 10.1186/s13014-021-01852-z.
9
Opportunistic body composition evaluation in patients with esophageal adenocarcinoma: association of survival with F-FDG PET/CT muscle metrics.食管腺癌患者的机会性身体成分评估:与 F-FDG PET/CT 肌肉指标相关的生存情况。
Ann Nucl Med. 2020 Mar;34(3):174-181. doi: 10.1007/s12149-019-01429-7. Epub 2019 Dec 10.
10
3'-deoxy-3'-[¹⁸F]-fluorothymidine PET/CT in early determination of prognosis in patients with esophageal squamous cell cancer: comparison with [¹⁸F]-FDG PET/CT.3'-脱氧-3'-[¹⁸F]-氟代胸苷PET/CT在食管鳞状细胞癌患者预后早期判定中的应用:与[¹⁸F]-FDG PET/CT的比较
Strahlenther Onkol. 2015 Feb;191(2):141-52. doi: 10.1007/s00066-014-0744-8. Epub 2014 Aug 28.

引用本文的文献

1
18F-FDG PET/CT-based deep radiomic models for enhancing chemotherapy response prediction in breast cancer.基于18F-FDG PET/CT的深度放射组学模型用于增强乳腺癌化疗反应预测
Med Oncol. 2025 Aug 11;42(9):425. doi: 10.1007/s12032-025-02982-0.
2
Machine Learning and Deep Learning Hybrid Approach Based on Muscle Imaging Features for Diagnosis of Esophageal Cancer.基于肌肉成像特征的机器学习与深度学习混合方法用于食管癌诊断
Diagnostics (Basel). 2025 Jul 8;15(14):1730. doi: 10.3390/diagnostics15141730.
3
Synergic value of 3D CT-derived body composition and triglyceride glucose body mass for survival prognostic modeling in unresectable pancreatic cancer.

本文引用的文献

1
Enhancing Axillary Lymph Node Diagnosis in Breast Cancer with a Novel Photoacoustic Imaging-Based Radiomics Nomogram: A Comparative Study of Peritumoral Regions.基于新型光声成像的影像组学列线图增强乳腺癌腋窝淋巴结诊断:瘤周区域的比较研究
Acad Radiol. 2025 Mar;32(3):1274-1286. doi: 10.1016/j.acra.2024.10.018. Epub 2024 Nov 7.
2
Application of a Comprehensive Model Based on CT Radiomics and Clinical Features for Postoperative Recurrence Risk Prediction in Non-small Cell Lung Cancer.基于 CT 影像组学和临床特征的综合模型在非小细胞肺癌术后复发风险预测中的应用。
Acad Radiol. 2024 Jun;31(6):2579-2590. doi: 10.1016/j.acra.2023.11.028. Epub 2024 Jan 2.
3
三维CT衍生的身体成分与甘油三酯葡萄糖体质指数在不可切除胰腺癌生存预后建模中的协同价值
Front Nutr. 2025 Mar 19;12:1499188. doi: 10.3389/fnut.2025.1499188. eCollection 2025.
Multicentric development and evaluation of [F]FDG PET/CT and CT radiomic models to predict regional and/or distant recurrence in early-stage non-small cell lung cancer treated by stereotactic body radiation therapy.
多中心发展和评估 [F]FDG PET/CT 和 CT 放射组学模型,以预测立体定向体部放射治疗的早期非小细胞肺癌的局部和/或远处复发。
Eur J Nucl Med Mol Imaging. 2024 Mar;51(4):1097-1108. doi: 10.1007/s00259-023-06510-y. Epub 2023 Nov 21.
4
Prognostic Value of F-FDG PET Radiomics Features at Baseline in PET-Guided Consolidation Strategy in Diffuse Large B-Cell Lymphoma: A Machine-Learning Analysis from the GAINED Study.基于 F-FDG PET 影像组学特征的弥漫性大 B 细胞淋巴瘤 PET 引导巩固治疗策略的预后价值:来自 GAINED 研究的机器学习分析。
J Nucl Med. 2024 Jan 2;65(1):156-162. doi: 10.2967/jnumed.123.265872.
5
Imaging-based adipose biomarkers for predicting clinical outcomes of cancer patients treated with immune checkpoint inhibitors: a systematic review.基于成像的脂肪生物标志物预测接受免疫检查点抑制剂治疗的癌症患者的临床结局:一项系统综述
Front Oncol. 2023 Oct 17;13:1198723. doi: 10.3389/fonc.2023.1198723. eCollection 2023.
6
Preoperative prediction of clinical and pathological stages for patients with esophageal cancer using PET/CT radiomics.使用PET/CT影像组学对食管癌患者的临床和病理分期进行术前预测。
Insights Imaging. 2023 Oct 15;14(1):174. doi: 10.1186/s13244-023-01528-0.
7
Ensemble Machine Learning Model Incorporating Radiomics and Body Composition for Predicting Intraoperative HDI in PPGL.基于影像组学和体成分学的集成机器学习模型预测 PPGL 术中高碘血症。
J Clin Endocrinol Metab. 2024 Jan 18;109(2):351-360. doi: 10.1210/clinem/dgad543.
8
Multi-task deep learning-based radiomic nomogram for prognostic prediction in locoregionally advanced nasopharyngeal carcinoma.基于多任务深度学习的放射组学列线图在局部晚期鼻咽癌中的预后预测。
Eur J Nucl Med Mol Imaging. 2023 Nov;50(13):3996-4009. doi: 10.1007/s00259-023-06399-7. Epub 2023 Aug 19.
9
Prognostic role of radiomics-based body composition analysis for the 1-year survival for hepatocellular carcinoma patients.基于影像组学的身体成分分析对肝细胞癌患者1年生存率的预后作用。
J Cachexia Sarcopenia Muscle. 2023 Oct;14(5):2301-2309. doi: 10.1002/jcsm.13315. Epub 2023 Aug 17.
10
Association Between Visceral Fat Area and Cancer Prognosis: A Population-Based Multicenter Prospective Study.内脏脂肪面积与癌症预后的关系:一项基于人群的多中心前瞻性研究。
Am J Clin Nutr. 2023 Sep;118(3):507-517. doi: 10.1016/j.ajcnut.2023.07.001. Epub 2023 Jul 6.